Indian equity benchmarks staged
another stellar performance on Tuesday, rallying over one percent each and
settled at their fresh record closing highs aided by positive cues in the
global market. Both the S&P BSE Sensex and the NSE Nifty 50 settled above
crucial 43,250 and 12,600 levels, respectively. Key gauges traded on positive
note since the beginning, with optimism over Covid-19 vaccine as Pfizer Inc's
said its experimental COVID-19 vaccine was more than 90 percent effective based
on initial trial results, and they have so far found no serious safety
concerns, priming it for possible speedy regulatory approvals. Traders also
reacted positively to SBI Research report stated that a number of green shoots
are visible in the economy five months after easing restrictions. It also said
assuming that India escapes a second wave, the pandemic will subside by
February 2021. Local indices added gains in afternoon session, as the street
remained buoyed with private report stating that with economic activities
gathering pace post easing of lockdowns across the country, hiring activities
in most sectors have shown significant recovery in October over the previous
month. The momentum in the markets was also buoyed with oil minister Dharmendra
Pradhan's statement that India has invited global firms to invest in its
strategic petroleum reserves (SPRs) as the nation's energy consumption growth
would be fastest among large economies in coming decades. Adding more positivity,
the country's exports grew 22.47 per cent year-on-year to $6.75 billion in the
first week of November, mainly driven by healthy growth in pharmaceuticals,
gems and jewellery and engineering sectors. The exports during the first week
of November last year was $5.51 billion. Finally, the BSE Sensex rose 680.22
points or 1.60% to 43,277.65, while the CNX Nifty was up by 170.05 points or
1.36% to 12,631.10.
The US markets ended mostly lower
on Tuesday as traders continued to cycle out of tech stocks that benefited from
the coronavirus pandemic and into cyclical stocks that struggled. Stocks that
benefited from the coronavirus-induced lockdowns such as Zoom, Amazon and
Shopify saw further downside after falling sharply on Monday. There could be
more pain between now and then, as coronavirus cases in the US continue to
spike and have now topped 10 million. Even the most optimistic projections
suggest it will take months to distribute a vaccine, suggesting yesterday's
spike to record highs may have been overdone. However, Dow Jones Industrial
Average benefited from an advance by shares of Boeing, which spiked by 5.2
percent after a Private report said the FAA is set to lift its grounding order
on the aerospace giant's 737 MAX as early as next week. Traders also kept an
eye on the latest developments in Washington, as President Donald Trump
continues to refuse to concede to Joe Biden. Meanwhile, the Supreme Court also
attracted attention, as Justices heard arguments in case about Obamacare that
could lead to the entire healthcare reform law being struck down.
Magnifying their previous session
gains, crude oil futures ended higher on Tuesday as optimism over a potential
coronavirus vaccine continued to outweigh worries about the energy demand
outlook. After Pfizer reported that its coronavirus vaccine is more than 90%
effective, US President-elect Joe Biden heralded the positive new development
in the race for a vaccine but warned it will still be several months before
most of the country is inoculated. Meanwhile, the possibility of OPEC+ tweaking
their supply cut pact in the event of a drop in demand helped ease concerns
over excess supply. Crude oil futures for December surged $1.07 or 2.7 percent
to settle at $41.36 a barrel on the New York Mercantile Exchange. January Brent
crude rose $0.54 or 1.3 percent to settle at $42.94 a barrel on London's
Intercontinental Exchange.
Indian rupee ended weaker against
the US dollar on Tuesday, on increased demand for the greenback from importers
and banks. Sentiments remained fragile despite report that India's exports
showed signs of improvement with growth of 22.47 per cent year-on-year to $6.75
billion in the first week of November. The exports during the first week of
November last year was $5.51 billion. Meanwhile, SBI Research in its latest
report has said a number of green shoots are visible in the economy five months
after easing restrictions. Further, the report said that assuming that India
escapes a second wave, the pandemic will subside by February 2021.On the global
front; dollar edged down slightly on Tuesday and the Japanese yen recovered
some of the previous session's losses after news of progress towards a COVID-19
vaccine boosted risk appetite in global markets. Finally, the rupee ended at
74.18, 3 paise weaker from its previous close of 74.15 on Monday.
The FIIs as per Tuesday's data
were net buyer in both equity and debt segment. In equity segment, the gross
buying was of Rs 9078.24 crore against gross selling of Rs 4652.21 crore, while
in the debt segment, the gross purchase was of Rs 1366.51 crore with gross
sales of Rs 484.66 crore. Besides, in the hybrid segment, the gross buying was
of Rs 0.96 crore against gross selling of Rs 29.12 crore.
The US markets ended mostly lower
on Tuesday as vaccine optimism led investors away from market leaders and
toward cyclical stocks associated with economic recovery. Asian markets are
trading mostly in green on Wednesday as hopes for a successful coronavirus
vaccine lifted expectations of a swift reopening of the global economy, which
would help the region's heavily trade-dependent markets. Indian markets ended
at a record close for the second session on Tuesday, tracking gains in Asian
peers, as progress in coronavirus vaccine raised hopes of a global economic
recovery. Today, the markets are likely to get positive start tracking gains in
Asian peers. Traders will be taking encouragement as the health ministry said
the National Expert Group on Vaccine Administration for COVID-19 is in
conversation with all vaccine manufacturers, including domestic and foreign
ones, a day after Pfizer Inc. and BioNTech SE announced more than 90 per cent
efficacy of their potential vaccine for the coronavirus. Some support will come
as Commerce and Industry Minister Piyush Goyal and Minister of State Hardeep
Singh Puri held a virtual dialogue with their UK counterparts to review the
progress towards a post-Brexit Enhanced Trade Partnership with Britain, which
could lead to a free trade agreement in the future. Traders may take note that
The Centre has released Rs 6,195 crore to 14 states as monthly instalment of
post devolution revenue deficit grant. However, traders may be concerned with
report that India has reported nearly 44,679 fresh Covid-19 cases in the past
24 hours. The total caseload now stands at 8,635,754. The country's death toll
has mounted to 127,615. India has conducted the second-highest number of tests
for detection of Covid-19 cases in the world at 119.6 million, with rapid
antigen tests comprising 49 per cent and RT-PCR 46 per cent of the total tests
done till Tuesday, according to the Union health ministry. There may be some cautiousness
with ratings agency ICRA's statement that state government funded
infrastructure capital expenditure is expected to remain weak in the near term.
Meanwhile, as per a report, ACC, Adani Green, Balkrishna Industries, Ipca Labs,
and YES Bank have been included in the MSCI India index along with seven other
stocks. On other hand, Bosch, and LIC Housing Finance have been removed from
the list. The changes will be effective December 1, 2020. Telecom stocks will
be in focus with TRAI data showing that Bharti Airtel added 28.99 lakh users,
Reliance Jio added 18.64 lakh users, while Vodafone Idea lost 12.28 lakh users
in August. There will be some reaction in sugar stocks with a private report
that India has revived a proposal to get sugar mills to export 6 million tonnes
of the sweetener by incentivising overseas sales in the 2020/21 season, the
third year in a row, as part of efforts to cut surplus stocks and prop up local
prices. There will be some important earnings announcements too to keep the markets
buzzing.
Support and
Resistance: NSE (Nifty) and BSE (Sensex)
Index
|
Previous
close
|
Support
|
Resistance
|
NSE
Nifty
|
12,631.10
|
12,522.94
|
12,691.59
|
BSE
Sensex
|
43,277.65
|
42,853.02
|
43,509.37
|
Nifty Top volumes
Stock
|
Volume
|
Previous
close (Rs)
|
Support (Rs)
|
Resistance
(Rs)
|
(in
Lacs)
|
State
Bank of India
|
1,352.95
|
231.70
|
224.80
|
236.80
|
Tata
Motors NTPC
|
687.94
|
146.00
|
143.60
|
147.55
|
Indusind
Bank
|
597.59
|
835.20
|
788.80
|
875.80
|
ICICI
Bank
|
575.35
|
483.85
|
475.55
|
489.60
|
ITC
|
574.59
|
178.35
|
173.61
|
181.31
|
TCS has entered into agreement with Deutsche Bank AG under which TCS will acquire 100% of the shares of Postbank Systems AG from Deutsche Bank AG.
NTPC has commissioned 8 MW part capacity of 20 MW Auraiya Solar PV Project at Auraiya, Uttar Pradesh.
Tata Steel has entered into a memorandum of understanding with Hindustan Zinc to procure the firm's complete domestic zinc requirements.
Tech Mahindra has entered into a strategic partnership with Huddl.ai to launch remote collaboration solutions for enterprises globally.